Kristine M. Jacques - 01 Jan 2026 Form 4 Insider Report for Tenon Medical, Inc. (TNON)

Role
Director
Signature
/s/ Kristine M. Jacques
Issuer symbol
TNON
Transactions as of
01 Jan 2026
Net transactions value
$0
Form type
4
Filing time
05 Jan 2026, 20:50:56 UTC
Previous filing
15 Oct 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Jacques Kristine M Director 104 COOPER COURT, LOS GATOS /s/ Kristine M. Jacques 05 Jan 2026 0002017818

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TNON Common Stock Options Exercise $0 +10,146 $0.000000 10,146 01 Jan 2026 Direct F1
transaction TNON Common Stock Options Exercise $0 +583 +5.7% $0.000000 10,729 01 Jan 2026 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TNON Restricted Stock Units Options Exercise $0 -10,146 -50% $0.000000 10,147 01 Jan 2026 Common Stock 10,146 Direct F1, F2
transaction TNON Restricted Stock Units Options Exercise $0 -583 -54% $0.000000 492 01 Jan 2026 Common Stock 583 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents conversion of 10,146 restricted stock units ("RSUs") granted to the reporting person on October 13, 2025 into 10,146 shares of common stock of the Issuer on January 1, 2026.
F2 Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.
F3 Represents conversion of 583 RSUs granted to the reporting person on May 8, 2024 into 583 shares of common stock of the Issuer on January 1, 2026.